Isofol Medical AB (ISOFOL) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.089x

Based on the latest financial reports, Isofol Medical AB (ISOFOL) has a cash flow conversion efficiency ratio of -0.089x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.78 Million ≈ $-1.16 Million USD) by net assets (Skr120.62 Million ≈ $12.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Isofol Medical AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Isofol Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Isofol Medical AB debt and liabilities for a breakdown of total debt and financial obligations.

Isofol Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Isofol Medical AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
National Tyre & Wheel Limited F:N37	0.148x
WAPS Co. Ltd KQ:196700	0.023x
IMS SA WAR:IMS	0.157x
Tainwala Chemical and Plastic (I) Limited NSE:TAINWALCHM	-0.028x
HUTCHMED China Ltd LSE:HCM	-0.029x
Tek Seng Holdings Bhd KLSE:7200	0.087x
Almadex Minerals Ltd V:DEX	-0.007x
Games Operators SA WAR:GOP	0.091x

Annual Cash Flow Conversion Efficiency for Isofol Medical AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Isofol Medical AB from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see ISOFOL stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr107.87 Million ≈ $11.61 Million	Skr-51.94 Million ≈ $-5.59 Million	-0.481x	+10.62%
2024-12-31	Skr77.94 Million ≈ $8.39 Million	Skr-41.99 Million ≈ $-4.52 Million	-0.539x	-24.51%
2023-12-31	Skr121.43 Million ≈ $13.07 Million	Skr-52.54 Million ≈ $-5.65 Million	-0.433x	+64.10%
2022-12-31	Skr158.48 Million ≈ $17.05 Million	Skr-190.97 Million ≈ $-20.55 Million	-1.205x	-103.52%
2021-12-31	Skr318.23 Million ≈ $34.25 Million	Skr-188.43 Million ≈ $-20.28 Million	-0.592x	+75.41%
2020-12-31	Skr66.57 Million ≈ $7.16 Million	Skr-160.27 Million ≈ $-17.25 Million	-2.408x	-71.58%
2019-12-31	Skr104.91 Million ≈ $11.29 Million	Skr-147.21 Million ≈ $-15.84 Million	-1.403x	-302.20%
2018-12-31	Skr265.01 Million ≈ $28.52 Million	Skr-92.46 Million ≈ $-9.95 Million	-0.349x	-93.21%
2017-12-31	Skr343.03 Million ≈ $36.92 Million	Skr-61.94 Million ≈ $-6.67 Million	-0.181x	+98.06%
2016-12-31	Skr6.10 Million ≈ $656.35K	Skr-56.90 Million ≈ $-6.12 Million	-9.330x	+66.45%
2015-12-31	Skr1.32 Million ≈ $142.27K	Skr-36.77 Million ≈ $-3.96 Million	-27.812x	--

About Isofol Medical AB

ST:ISOFOL Sweden Biotechnology

Market Cap

$20.39 Million

Skr189.47 Million SEK

Market Cap Rank

#24975 Global

#506 in Sweden

Share Price

Skr0.67

Change (1 day)

+0.60%

52-Week Range

Skr0.58 - Skr1.86

All Time High

Skr33.00